{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:41:36Z","timestamp":1791290496583,"version":"4.3.0"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":607,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1002\/jcph.248","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T07:54:37Z","timestamp":1387266877000},"page":"574-583","source":"Crossref","is-referenced-by-count":50,"title":["Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention"],"prefix":"10.1002","volume":"54","author":[{"given":"Melanie R.","family":"Nicol","sequence":"first","affiliation":[{"name":"Eshelman School of Pharmacy; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Mathews","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M. A.","family":"Prince","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"},{"name":"Center for AIDS Research; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine B.","family":"Patterson","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Geller","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Mollan","sequence":"additional","affiliation":[{"name":"Center for AIDS Research; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mathews","sequence":"additional","affiliation":[{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L","family":"Kroetz","sequence":"additional","affiliation":[{"name":"UCSF School of Pharmacy; University of California; San Francisco NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D. M.","family":"Kashuba","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy; University of North Carolina; Chapel Hill NC USA"},{"name":"UNC School of Medicine; University of North Carolina; Chapel Hill NC USA"},{"name":"Center for AIDS Research; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"10.1002\/jcph.248-BIB0001|jcph248-cit-0001","unstructured":"UNAIDS UNAIDS report on the global AIDS epidemic http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_en.pdf"},{"key":"10.1002\/jcph.248-BIB0002|jcph248-cit-0002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4155\/cli.12.155","article-title":"HIV pre-exposure prophylaxis trials: the road to success","volume":"3","author":"Nicol","year":"2013","journal-title":"Clin Investig."},{"issue":"7","key":"10.1002\/jcph.248-BIB0003|jcph248-cit-0003","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":"Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention","volume":"26","author":"van der Straten","year":"2012","journal-title":"AIDS."},{"key":"10.1002\/jcph.248-BIB0004|jcph248-cit-0004","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/QAD.0b013e328270385a","article-title":"Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis","volume":"21","author":"Dumond","year":"2007","journal-title":"AIDS."},{"key":"10.1002\/jcph.248-BIB0005|jcph248-cit-0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/clpt.2010.189","article-title":"Pharmacologic opportunities for HIV prevention","volume":"88","author":"Nicol","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.248-BIB0006|jcph248-cit-0006","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/infdis\/jir059","article-title":"Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men","volume":"203","author":"Brown","year":"2011","journal-title":"J Infect Dis."},{"key":"10.1002\/jcph.248-BIB0007|jcph248-cit-0007","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QAI.0b013e3181ae69c5","article-title":"Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women","volume":"51","author":"Dumond","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"112","key":"10.1002\/jcph.248-BIB0008|jcph248-cit-0008","doi-asserted-by":"crossref","first-page":"112re114","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med."},{"key":"10.1002\/jcph.248-BIB0009|jcph248-cit-0009","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","volume":"78","author":"Ho","year":"2005","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.248-BIB0010|jcph248-cit-0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov."},{"key":"10.1002\/jcph.248-BIB0011|jcph248-cit-0011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol Sci."},{"key":"10.1002\/jcph.248-BIB0012|jcph248-cit-0012","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet."},{"key":"10.1002\/jcph.248-BIB0013|jcph248-cit-0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-642-14541-4_10","article-title":"Molecular mechanisms of drug transporter regulation","volume":"201","author":"Tirona","year":"2011","journal-title":"Handb Exp Pharmacol."},{"key":"10.1002\/jcph.248-BIB0014|jcph248-cit-0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.248-BIB0015|jcph248-cit-0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-200107270-00004","article-title":"P-Glycoprotein, transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS."},{"key":"10.1002\/jcph.248-BIB0016|jcph248-cit-0016","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1177\/38.11.1976674","article-title":"Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditions","volume":"38","author":"Finstad","year":"1990","journal-title":"J Histochem Cytochem."},{"key":"10.1002\/jcph.248-BIB0017|jcph248-cit-0017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1089\/aid.2013.0032","article-title":"Expression of transporters and metabolizing enzymes in the female lower genital tract: implications on microbicide research","volume":"29","author":"Zhou","year":"2013","journal-title":"AIDS Res Hum Retroviruses."},{"key":"10.1002\/jcph.248-BIB0018|jcph248-cit-0018","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jcph.132","article-title":"Expression of membrane drug efflux transporters in the sigmoid colon of HIV-infected and uninfected men","volume":"53","author":"De Rosa","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.248-BIB0019|jcph248-cit-0019","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":"Mechanism of active renal tubular efflux of tenofovir","volume":"50","author":"Ray","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1002\/jcph.248-BIB0020|jcph248-cit-0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/00498250500354493","article-title":"Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites","volume":"35","author":"Mallants","year":"2005","journal-title":"Xenobiotica."},{"key":"10.1002\/jcph.248-BIB0021|jcph248-cit-0021","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e31815e7478","article-title":"Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients","volume":"47","author":"Kiser","year":"2008","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.248-BIB0022|jcph248-cit-0022","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1002\/jcph.248-BIB0023|jcph248-cit-0023","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/dmd.104.002626","article-title":"Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV","volume":"33","author":"Walker","year":"2005","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.248-BIB0024|jcph248-cit-0024","unstructured":"Selzentry [package insert] http:\/\/www.viivhealthcare.com\/\u223c\/media\/Files\/G\/GlaxoSmithKline-Plc\/pdfs\/us_selzentry.pdf"},{"key":"10.1002\/jcph.248-BIB0025|jcph248-cit-0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/FPC.0b013e3283402efb","article-title":"Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T\u2009>\u2009C polymorphism","volume":"20","author":"Siccardi","year":"2010","journal-title":"Pharmacogen Genom."},{"key":"10.1002\/jcph.248-BIB0026|jcph248-cit-0026","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc."},{"key":"10.1002\/jcph.248-BIB0027|jcph248-cit-0027","unstructured":"Viread [package insert] http:\/\/www.gilead.com\/\u223c\/media\/Files\/pdfs\/medicines\/liver-disease\/viread\/viread_pi.pdf"},{"key":"10.1002\/jcph.248-BIB0028|jcph248-cit-0028","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol."},{"key":"10.1002\/jcph.248-BIB0029|jcph248-cit-0029","first-page":"189","article-title":"The number and distribution of lymphoid follicles in the human large intestine","volume":"149","author":"Langman","year":"1986","journal-title":"J Anat."},{"key":"10.1002\/jcph.248-BIB0030|jcph248-cit-0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2125.2005.02389.x","article-title":"Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract","volume":"60","author":"Thorn","year":"2005","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.248-BIB0031|jcph248-cit-0031","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.248-BIB0032|jcph248-cit-0032","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/clpt.2009.226","article-title":"The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology","volume":"87","author":"Kroetz","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.248-BIB0033|jcph248-cit-0033","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/17425255.2012.678048","article-title":"Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development","volume":"8","author":"Lai","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"10.1002\/jcph.248-BIB0034|jcph248-cit-0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/ecp.11.66","article-title":"Inflammation-mediated changes in drug transporter expression\/activity: implications for therapeutic drug response","volume":"5","author":"Cressman","year":"2012","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1002\/jcph.248-BIB0035|jcph248-cit-0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/clpt.2010.359","article-title":"Transporter-mediated drug-drug interactions","volume":"89","author":"Zhang","year":"2011","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.248-BIB0036|jcph248-cit-0036","first-page":"577","article-title":"P-Glycoprotein expression is increased in human secretory and gestational endometrium","volume":"65","author":"Axiotis","year":"1991","journal-title":"Lab Invest."},{"key":"10.1002\/jcph.248-BIB0037|jcph248-cit-0037","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1124\/dmd.106.011478","article-title":"Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors","volume":"35","author":"Evseenko","year":"2007","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.248-BIB0038|jcph248-cit-0038","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1023\/B:PHAM.0000033017.52484.81","article-title":"P-Glycoprotein (P-gp\/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro","volume":"21","author":"Kim","year":"2004","journal-title":"Pharm Res."},{"key":"10.1002\/jcph.248-BIB0039|jcph248-cit-0039","unstructured":"Center for Disease Control CDC fact sheet. New infections in the United States http:\/\/www.cdc.gov\/nchhstp\/newsroom\/docs\/2012\/HIV-Infections-2007-2010.pdf"},{"key":"10.1002\/jcph.248-BIB0040|jcph248-cit-0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.248","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.248\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:03:06Z","timestamp":1657803786000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.248"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.248","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,2]]}}}